HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyun Ju Kim Selected Research

hexamethylenebis(dimethyl- (3- phthalimidopropyl)ammonium bromide) (W 84)

12/2009Active principle of kimchi, 3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid, retards fatty streak formation at aortic sinus of apolipoprotein E knockout mice.
12/20073-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid, an active principle of kimchi, inhibits development of atherosclerosis in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hyun Ju Kim Research Topics

Disease

12Neoplasms (Cancer)
12/2021 - 06/2014
10Inflammation (Inflammations)
03/2021 - 10/2009
9Hypertension (High Blood Pressure)
01/2022 - 01/2007
9Body Weight (Weight, Body)
09/2019 - 08/2005
8Proteinuria
01/2012 - 01/2009
5Atherosclerosis
02/2018 - 12/2007
5Azotemia
06/2011 - 06/2009
4Hepatocellular Carcinoma (Hepatoma)
02/2020 - 10/2018
4Stomach Neoplasms (Stomach Cancer)
01/2020 - 06/2003
4Infections
10/2018 - 03/2008
3Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2014 - 09/2007
3Chronic Kidney Failure (Chronic Renal Failure)
10/2010 - 10/2009
2Breast Neoplasms (Breast Cancer)
01/2021 - 03/2019
2COVID-19
01/2021 - 01/2021
2Neoplasm Metastasis (Metastasis)
03/2019 - 12/2014
2Esophageal Neoplasms (Esophageal Cancer)
01/2019 - 07/2017
2Liver Neoplasms (Liver Cancer)
01/2019 - 06/2014
2Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2018 - 06/2015
2Pain (Aches)
01/2018 - 01/2014
2Psoriasis (Pustulosis Palmaris et Plantaris)
12/2017 - 02/2016
2Hemorrhage
12/2017 - 09/2010
2Liver Diseases (Liver Disease)
01/2015 - 03/2008
2Diabetes Mellitus
09/2014 - 08/2005
2Hypercholesterolemia
01/2009 - 12/2005
2Hyperglycemia
07/2008 - 08/2005
1Glioma (Gliomas)
03/2022
1Diffuse Intrinsic Pontine Glioma
03/2022
1Necrosis
03/2022
1Hypothermia
01/2022
1Leukemia
12/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2021
1Margins of Excision
07/2021
1Insulin Resistance
12/2020
1Lung Injury
12/2020
1Cytokine Release Syndrome
12/2020
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2020
1Erythema
01/2020

Drug/Important Bio-Agent (IBA)

7LipidsIBA
02/2018 - 07/2008
6CholesterolIBA
08/2011 - 12/2005
6NADPH Oxidases (NAD(P)H oxidase)IBA
06/2011 - 10/2009
5AntioxidantsIBA
06/2015 - 12/2007
4EnzymesIBA
01/2015 - 01/2009
4Proteins (Proteins, Gene)FDA Link
06/2014 - 09/2007
4Fatty Acids (Saturated Fatty Acids)IBA
12/2010 - 01/2009
3SodiumIBA
01/2022 - 01/2007
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 12/2010
3CarbohydratesIBA
06/2014 - 06/2009
3Apolipoproteins E (ApoE)IBA
08/2011 - 12/2009
3Liver X ReceptorsIBA
10/2010 - 01/2009
3NF-kappa B (NF-kB)IBA
03/2010 - 09/2007
2ProdigiosinIBA
12/2021 - 03/2021
2Biological ProductsIBA
03/2021 - 09/2019
2LeptinIBA
09/2019 - 12/2010
2Antiviral Agents (Antivirals)IBA
10/2018 - 03/2008
2AntigensIBA
10/2018 - 01/2014
2Biomarkers (Surrogate Marker)IBA
10/2018 - 01/2014
2CytokinesIBA
02/2017 - 08/2010
2Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2017 - 09/2011
2Thyroxine (Levothyroxine)FDA LinkGeneric
01/2015 - 12/2014
2Immunosuppressive Agents (Immunosuppressants)IBA
09/2014 - 01/2013
2Glutathione (Reduced Glutathione)IBA
08/2011 - 03/2010
2ApolipoproteinsIBA
11/2010 - 12/2009
2Plasminogen Activator Inhibitor 1IBA
11/2010 - 10/2009
2Carrier Proteins (Binding Protein)IBA
10/2010 - 06/2009
2hexamethylenebis(dimethyl- (3- phthalimidopropyl)ammonium bromide) (W 84)IBA
12/2009 - 12/2007
23- (4'- hydroxyl- 3',5'- dimethoxyphenyl)propionic acidIBA
12/2009 - 12/2007
2FructoseIBA
07/2008 - 09/2007
2ethyl acetateIBA
09/2007 - 06/2007
2PolyphenolsIBA
09/2007 - 06/2007
1dipinacoline glutamateIBA
03/2022
1Bevacizumab (Avastin)FDA Link
03/2022
1Antihypertensive Agents (Antihypertensives)IBA
01/2022
1ORALIT (ORS)IBA
01/2022
1Atrial Natriuretic Factor (ANF)IBA
01/2022
1oryeongsanIBA
01/2022
1Ethanol (Ethyl Alcohol)IBA
12/2021
1Oxygen (Dioxygen)IBA
01/2021
1AnkyrinsIBA
01/2021
1ResveratrolIBA
12/2020
1BerberineIBA
12/2020
1sulforaphaneIBA
12/2020
1GenisteinIBA
12/2020
1QuercetinIBA
12/2020
1CurcuminIBA
12/2020
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
12/2020
1SiliconesIBA
01/2020
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020

Therapy/Procedure

15Radiotherapy
03/2022 - 12/2014
7Therapeutics
01/2020 - 03/2008
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2020 - 05/2015
3Oral Administration
09/2019 - 08/2005
3Chemoradiotherapy
01/2019 - 07/2017
2Adjuvant Radiotherapy
07/2021 - 06/2015
2Salvage Therapy
11/2018 - 05/2015
2Nephrectomy
12/2010 - 10/2009
1Perioperative Period
01/2022
1Bioreactors (Bioreactor)
12/2021
1Cystectomy
07/2021
1Re-Irradiation
10/2020
1Gastrectomy
01/2020